Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Clinical trial NCT01026337 · COMPLETED
Trial details
- NCT number
- NCT01026337
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-04-01
- Primary completion
- 2015-12-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.